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Abstract  This study investigated the presence or absence 
of Epstein-Barr virus and Human papilloma virus genes in 
ameloblastoma, in order to elucidate the genetic origin of this 
tumour. Methods and Material: 89 archived formalin-fixed 
paraffin-embedded specimens of ameloblastoma from the 
year 2000-2010 were genotyped by polymerase chain 
reaction for Epstein-Barr virus and Human papilloma virus 
genes Results: None of the 89 ameloblastoma cases used for 
this study tested positive for Epstein-Barr virus and Human 
papilloma virus genes. Conclusions: This study suggested 
that Epstein-Barr virus and Human papilloma virus genes 
may likely not be involved in the aetiopathogenesis of 
ameloblastoma in Ibadan environment. Key Messages: 
Studies have suggested that HPV might be implicated in the 
pathogenesis of ameloblastoma. In this study none of the 
extracted DNA samples from the 89 ameloblastoma cases 
amplified for HPV primer in the PCR, as this may possibly 
clear the role of this virus in the etiopathogenesis of 
ameloblastoma or may indicate need for other primers. 
Further investigation should be done to clarify EBV role in 
ameloblastoma. 
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1. Introduction 
Ameloblastomas are an unfathomable group of oral 
tumors and the most common odontogenic tumor, which 
occur largely on the basis of the histologic similarities of 
the tumor and the developing enamel organ. They are 
named as a result of their resemblance to cells of the 
enamel-forming organ (1). There is considerable variation in 
histological patterns, and are classified as follicular, 
plexiform, acanthomatous, granular cell, basal cell and 
desmoplastic ameloblastoma (3). Of these, the follicular and 
plexiform types are the most common (4). Ameloblastomas 
constitute almost half (48.9%) of the odontogenic tumors 
with female-to-male and maxilla-to-mandible ratios of 1:1.7 
and 1:8 respectively (5). Ameloblastoma is notorious for its 
recurrences although it is benign in nature. 
Ameloblastoma has also been associated with the most 
complex group of pathogenic viruses. Some authors have 
hypothesized that Human papilloma virus (HPV) might 
play a key role also in the pathogenesis of ameloblastoma. 
However, the results reported in the literature are quite 
controversial and were not precise (6).  Human papilloma 
viruses (HPV) are members of the papilloma viridae family 
that infect epithelial cells exclusively. More than 100 types 
of HPV have been identified, differing in the regulatory 
sequences and coding potential of their genomes (7), 
although all types of HPV have the same general 
organization of the genome (7). Another important virus 
often associated with various neoplastic developments is the 
Epstein Barr Virus (EBV) which is a double stranded DNA 
virus of approximately 175kb in length (8), EBV is a 
member of the herpesviridae family, gammaherpesviridae 
subfamily. Although considerable insight has been gained 
into EBV as an important aetiologic factor in various benign 
and malignant tumours, virtually little is known about the 
relationship between EBV and ameloblastoma. At the time 
of this study, there is no study in Nigeria that have 
revealed/reported the role played by these viruses (EBV and 
HPV) or their presence in ameloblastoma.  
2. Aim 
The aim of this study was to screen for presence or 
absence of EBV and HPV genes in ameloblastoma cases in 
Ibadan 
3. Objectives of the Study  
To assess the presence or absence of Epstein-Barr virus 
and Human papilloma virus genes in ameloblastoma using 
polymerase chain reaction method and to determine if there 
is a correlation between EBV and HPV infection and 
ameloblastoma. 
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4. Subjects and Methods 
4.1. Materials 
Eighty-nine (89) blocks of formalin-fixed 
paraffin-embedded tissues samples diagnosed as 
ameloblastoma deposited from between the years 2000 and 
2010 were retrieved from the archives of the Department of 
Oral Pathology, College of Medicine of the University of 
Ibadan, Nigeria. A formalin-fixed paraffin-embedded 
control (negative) sample of normal salivary gland was 
selected from the archives of the same institution, as we do 
not have confirmed tissues with any ofthe viruses as positive 
sample. The ethical approval for this research was obtained 
from the UI/UCH joint ethical committee. 
4.2. Methods 
To de-paraffinized the tissue samples, method of Coura et 
al.,9 was modified. 5µm sections were cut from each 
formalin-fixed paraffin-embedded tissue block using a 
microtome after re-embedded in fresh molten-wax and 
subsequently placed in 2.5 ml Eppendorf tubes. The sections 
were then incubated (after adding 2ml of xylene to it in 
Eppendorf tubes) incubated in a shaking water uniscope 
SM101 ( Surgifriend) bath which is previously set at 55oC 
for 30 minutes, after which the xylene was carefully 
pippetted off and the process was repeated two other times. 
Residual xylene was removed by adding 2ml of absolute 
ethanol and incubating at 55oC for 5 minutes. After 5 
minutes the ethanol was pippetted off and the process was 
repeated two other times. The residual ethanol was then 
removed by incubating at 55oC for 30 minutes. The tissue 
pellets was re-suspended by vortexing. 
4.3. DNA Extraction 
DNA was extracted from de-paraffinized tissue pellets 
using 70 µl of digestion buffer made up of 50mM KCl, 
1.5mM MgCl2, 10mM Tris-HCl, 0.45% (v/v) Tween-20, 
and 10mg/ml Proteinase-K (pH 8.3) and incubated in a Stuart 
orbital incubator S150 at 36oC overnight. After overnight 
incubation, proteinase-K was in-activated by incubating in a 
shaking water bath at 95oC for 10 minutes. It was thereafter 
vortexed and spun in a Hermle-2323 centrifuge at 7000rpm 
for 5 minutes. Subsequently, the supernatant was collected in 
autoclaved PCR tubes and stored at -20oC for DNA 
amplification. 
4.4. DNA Amplification 
Extracted DNA samples were subjected to polymerase 
chain reaction amplification. Briefly, the reactions were 
performed in a final volume of 25µl containing 1.5µl of 
template DNA, 0.5µl dNTPs, 5µl PCR Buffer, 15.4µl sterile 
water, 1.5 MgCl2, 0.1 Taq polymerase,  0.5µl of each 
forward and reverse primers (Integrated DNA Technologies, 
Coral ville, Iowa, U.S.A). The primers used in the 
genotyping reactions are shown in table 1. Samples 
containing the amplification mix were subjected to forty (40) 
amplification cycles. Conditions for the amplification were 
with an initial denaturation at 94oC for 5 minutes which was 
followed by a subsequent denaturation step at 94oC for 60 
seconds, an annealing step at 50oC for 60 seconds and initial 
extension step at 72oC for 60 seconds which was followed by 
a final extension step at 72oC for 10 minutes. 10µl aliquots of 
polymerase chain reaction amplicon was subjected to 
electrophoresis on 1.5% agarose gel followed by ethidium 
bromide staining and viewed on a photo documentation 
system. The primers used in this study were established EBV 
(20) and HPV (21, 22, 23) primers, as reported in previous 
studies. 
Table 1.  Primers used for the genotyping reactions 
Genes Primer sequence 
Barf 1 (EBV) 
Forward 5´-GGTGAAGCCTCTAACGCTGTCT-3´ 
Reverse 5´-TCACGGTGCATGTCACAGTAAG-3´ 
PGMY (HPV) 
Forward 5´-GCACAGGGACATAACAATGG-3´ 
5. Results 
All the 89 extracted DNA samples from the 
ameloblastoma cases were amplified for EBV and HPV 
genes by polymerase chain reaction (PCR) using Barf primer 
for Epstein-Barr virus and PGMY primer for Human 
papilloma virus genes. 
In all the 89 cases tested by polymerase chain reaction, 
Epstein-Barr virus and Human papilloma virus genes of any 
size did not amplify in any case. Negative control sample 
(-ve) from normal salivary gland was included, which show 
no positive amplification for all the genes by polymerase 
chain reaction. See table 2,3and figure 1-6 for summary. 
Table 2  HPV and EBV genotyping features in different histological types of ameloblastoma. 
Types of ameloblastoma Genes in number and percentage (n/%) 
Telangiectatic HPV EBV 
Follicular 0/0.0 0/0.0 
Plexiform 0/0.0 0/0.0 
Acanthomatous 0/0.0 0/0.0 
Cystic 0/0.0 0/0.0 
Demoplastic 0/0.0 0/0.0 
Mixed Plexiform/Follicular 0/0.0 0/0.0 
Unspecified 0/0.0 0/0.0 
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Table 3.  HPV and EBV genotyping features in different maxillofacial sites 
Types of ameloblastoma Genes in number and percentage (n/%) 
Mandible HPV EBV 
Maxilla 0/0.0 0/0.0 
Palate 0/0.0 0/0.0 
Buccal cavity 0/0.0 0/0.0 
Unspecified 0/0.0 0/0.0 
 
Figure 1.  PCR for the HPV gene using primer PGMY did not yield any amplicons from ameloblastoma cases (lane 1-34) and a negative control sample 
(normal salivary gland) in –ve lane.  The DNA ladder 1kb is in lane M. 
 
Figure 2.  PCR for the HPV gene using primer PGMY did not yield any amplicons from ameloblastoma cases (lane 34-66). The DNA ladder 1kb is in lane 
M. 
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Figure 3.  PCR for the HPV gene using primer PGMY did not yield any amplicons from ameloblastoma cases (lane 67-89). The DNA ladder 1kb is in lane 
M. 
 
Figure 4.  PCR for the (EBV) gene using Barf primer which did not amplify in ameloblastoma cases (lane 1-33) and a negative control sample (normal 
salivary gland) in lane -ve. The DNA ladder 1kb is in lane M.  
 
Figure 5.  PCR for the (EBV) gene using Barf primer which did not amplify in ameloblastoma cases (lane 34-66) and a negative control sample (normal 
salivary gland) in lane (-). The DNA ladder 1kb is in lane M.  
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Figure 6.  PCR for the (EBV) gene using Barf primer which did not amplify in ameloblastoma cases (lane 34-66) and a negative control sample (normal 
salivary gland) in lane -ve. The DNA ladder 1kb is in lane M.  
6. Discussion 
This study attempted to demonstrate the presence of EBV 
and HPV genes in archived formalin-fixed 
paraffin-embedded ameloblastoma cases by using the 
polymerase chain reaction method. 
None of the extracted DNA samples from ameloblastoma 
cases amplified for Barf1 (EBV) primer in the polymerase 
chain reaction. This is similar to the immunohistochemical 
report of Ayoub et al.,2 where only one out of 15 examined 
benign ameloblastoma showed positive EBV 
immunoreactions, since all patients included in this study 
were of Nigerian origin, one cannot completely exclude that 
EBV might be possibly involved at least in a subset of 
ameloblastomas occurring in subjects from other geographic 
areas, as commonly happens in other virus-related neoplastic 
disorders. The result in this study conflicts with the report of 
(10). It was suggested that the use of only limited EBV 
genes for the PCR detection might result in a false negative 
or a false positive detection of oral tumours which likely 
may be the cause of total negative result in this study (10). 
Little is known about the relationship between EBV genes 
and oral tumours (10). Moreover, the work done correlating 
the EBV as a viral aetiology with the occurrence of 
ameloblastoma is modest in the literature (10; 11). 
It has been recently suggested that HPV might somehow 
be implicated in the pathogenesis of ameloblastoma, the 
most common odontogenic tumour usually associated with a 
benign biologic behaviour (6). In this study none of the 
extracted DNA samples from the 89 ameloblastoma cases 
amplified for PGMY (HPV) primer , as this may likely rule 
out the possibility of this virus in the etiopathogenesis of 
ameloblastoma. This result differs from the work of 
Mokhtari-Azad et al., (12) in Iran, who found that 32% 
(32/100) of ameloblastomas cases worked on were positive 
for HPV-DNA. This difference probably stemmed from the 
fact that while this present study used only one type of HPV 
primer, they used fourteen different HPV primers that target 
different regions of the HPV genome. Studies have shown 
that more than one hundred types of HPV have been 
identified, differing in the regulatory sequences and coding 
potential of their genomes (7). It has been suggested in 
some studies (13) that the presence of this virus is only a 
contamination of the overlying surface squamous 
epithelium (13), as this was also suggested earlier by Van 
Heerden et al., (14). Just as this study, results have 
reasonably rule out any implication of HPV in 
ameloblastoma (6) while it has been stressed that the 
presence of HPV-DNA positivity in ameloblastoma likely 
represented a secondary surgically acquired contamination 
from the overlying oral mucosa or a secondary event rather 
than a true infection (14, 15). Discrepancies in study design 
may also explain the lack of consensus on the role of HPV in 
oral carcinogenesis (16). HPV is also considered an oral 
mucosa pathogen, with reported prevalence ranging from 0% 
to 60% (17, 18, and 19). 
7. Conclusion 
Although the viral aetiology, either HPV or EBV, of 
ameloblastoma showed a great contradiction in the 
literature, it must be noted that a difference in geographic 
distribution might partially explain these conflicting results 
as commonly happens in other virus-related disorders, 
hence, further studies utilizing much more advanced 
research tools such as in situ hybridization and PCR 
analysis are highly recommended (2) 
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